Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-10-11

Opinion for Concordia International Corp (CXR-T)

Signal Price Bias Subject Owned
DON'T BUY $1.490 OPTIMISTIC NORTH AMERICAN - LARGE No

She wouldn’t be buying this now, even though the stock price has come down dramatically from what it was a few years ago. This has only been public for about 4-5 years, and they’ve been buying assets. There is a lot of pricing pressure on the drugs they bought and paid a lot for. Has a lot of debt on their balance sheet. Debt to Enterprise EBITDA is over 11X. There is a big question as to how they are going to repay the debt when it comes due. Based on what they have now, it doesn’t seem sufficient.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management

No Comments.


You must be logged in to comment.